Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

5α-reductase inhibitors may cause persistent sexual dysfunction and depression, needing more research on long-term effects.

Finasteride may affect PNMT, causing side effects.

The new saw palmetto extract effectively inhibits an enzyme linked to prostate enlargement and may be as good as standard treatments.

Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.

Some gonadal hormone drugs can block filovirus entry into cells.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

The effectiveness of platelet-rich plasma for erectile dysfunction is still unclear.

4-aminopyridine helps skin wounds heal faster and better.

A reliable method was developed to measure Finasteride and Tadalafil together, showing they degrade under certain conditions.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Post-drug syndromes are often overlooked, and better systems and education are needed to improve drug safety.

PPCM microspheres can effectively release finasteride over 42 days.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Finasteride may be linked to Peyronie’s disease, but more research is needed.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

The new method for making Finasteride is cheaper and safer for large-scale production.